Century Report
KRAS Drug Cracks Pancreatic Cancer - TCR 05/09/26
The 20-Second Scan * Researchers reported in the New England Journal of Medicine that an experimental drug targeting a family of mutant KRAS proteins extended survival in patients with deadly pancreatic cancer in a small clinical trial. * Washington state's Peninsula school district said it expects to save approximately $220,